The percentage of individuals with liver fibrosis or cirrhosis was 9% among PLWH and 8% in HIV-negative participants, whereas ALT elevation was more common among PLWH (49% vs 37%, table 2). This evidence concerns the gene GPT and Hepatic fibrosis.